Skip to main content

Select Drug Profiles

ACR 2017, Conference Correspondent
Active Treatment Leads to Improved Myocardial Function in Patients with Active RA
Read More
ACR 2017, Conference Correspondent
Suboptimal EHR Reporting of Clinical Measures in RA Patients Receiving a Biologic or Targeted Synthetic DMARD
Read More
ACR 2017, Conference Correspondent
Both Tofacitinib and Baricitinib in Combination with Methotrexate Are Efficacious in Patients with RA
Read More
ACR 2017, Conference Correspondent
No Increased Cardiovascular Risk in Patients with RA Who Newly Initiated Tocilizumab versus Abatacept
Read More
Original Research
Medication Adherence, Treatment Patterns, and Dose Reduction in Patients with Metastatic Castration-Resistant Prostate Cancer Receiving Abiraterone Acetate or Enzalutamide
Ajay S. Behl, PhD, Lorie A. Ellis, PhD, Dominic Pilon, MA, Yongling Xiao, PhD
Ajay S. Behl, PhD; Lorie A. Ellis, PhD; Dominic Pilon, MA; Yongling Xiao, PhD; Patrick Lefebvre, MA
Stakeholder Perspective
A First Step Toward Improving the Complex Approach to Metastatic Prostate Cancer Management
Gary M. Owens, MD
by Gary M. Owens, MD
Read More
Original Research
The Relative Burden of Menopausal and Postmenopausal Symptoms versus Other Major Conditions: A Retrospective Analysis of the Medical Expenditure Panel Survey Data
Annlouise R. Assaf, PhD, Andrew G. Bushmakin, MS, Nina Joyce, PhD, Michael J. Louie, MD, MPH, MSc, Michael Flores, MPH, Margaret Moffatt, MPH
Annlouise R. Assaf, PhD; Andrew G. Bushmakin, MS; Nina Joyce, PhD; Michael J. Louie, MD, MPH, MSc; Michael Flores, MPH; Margaret Moffatt, MPH
Stakeholder Perspective
Hormone Therapy Remains Effective for Treating Menopausal Symptoms, May Save Overall Costs
JoAnn V. Pinkerton, MD, FACOG, NCMP
by JoAnn V. Pinkerton, MD, FACOG, NCMP
Read More
Perspectives
Health Inequities in America
David B. Nash, MD, MBA
David B. Nash, MD, MBA
Read More
Original Research, Practice Management
Costs and Effectiveness of Mindfulness-Based Art Therapy versus Standard Breast Cancer Support Group for Women with Cancer
Katherine M. Prioli, MS, Laura T. Pizzi, PharmD, MPH, Kathryn M. Kash, PhD, Andrew B. Newberg, MD, Anna Marie Morlino, PharmD, Michael Matthews, BS, Daniel A. Monti, MD
Katherine M. Prioli, BS; Laura T. Pizzi, PharmD, MPH; Kathryn M. Kash, PhD; Andrew B. Newberg, MD; Anna Marie Morlino, PharmD; Michael J. Matthews, BS; Daniel A. Monti, MD
Stakeholder Perspective
Creative Therapeutic Activities and Support Groups Benefit All Those Involved in Cancer Care
Linda Bily, MA, CSA, OPN-CG
by Linda Bily, MA, CSA, OPN-CG
Read More
Practice Management
Value-Based Perspectives on the Management of Allergic Rhinitis
Eli O. Meltzer, MD, Don A. Bukstein, MD, Paul M. Hamrah, MS, PharmD, Nikkia Scott, PharmD, John A. Welz, MPH
Read More
Breast Cancer, Oncology
Abemaciclib, a New CDK4/CDK6 Inhibitor, Added to Fulvestrant Extends PFS in Advanced HR-Positive, HER2-Negative Breast Cancer
Phoebe Starr
Read More
Page 81 of 244
Results 801 - 810 of 2434